CDC Cadillac Ventures Inc

Feronia Inc. ("Feronia" or the "Company") (TSX VENTURE:FRN) is pleased to
announce that it has completed the first tranche of a $25 million financing led
by CDC Group plc ("CDC"), the UK Government's Development Finance Institution
("DFI"). All amounts in this release are expressed in US dollars unless
otherwise indicated.


CDC has acquired 151,496,000 common shares of the Company at a purchase price of
CAD$0.10 per share for an aggregate purchase price of $14.5 million pursuant to
the terms of a subscription agreement entered into with the Company. Also in
connection with the financing, the African Agriculture Fund ("AAF"), which is
the Company's largest shareholder, acquired 78,360,000 common shares through its
subsidiary Golden Oil Holdings Limited for an aggregate purchase price of $7.5
million. The AAF is a $243m African private equity fund managed by Phatisa,
which has a portfolio of investments across Africa in the agriculture and food
sectors.


Concurrently with the investments from CDC and the AAF, Feronia's Executive
Chairman, Mr. Ravi Sood, acquired 1,562,250 common shares for an aggregate
purchase price of $150,000. A number of other qualifying investors have also
subscribed for an aggregate of 29,685,000 common shares in the financing, for an
aggregate purchase price of approximately $2.85 million, of which approximately
$1.38 million was completed in connection with the first tranche. The remaining
subscriber is expected to close in the coming days. The purchase price of all
shares issued in connection with the private placement will be CAD$0.10 per
share. The common shares issued pursuant to the first tranche of the private
placement are subject to a statutory hold period which expires on March 8, 2014.


Proceeds from the financing will be used primarily to fund the Company's
existing and future oil palm replanting programme.


Following completion of the financing, CDC will directly hold approximately
27.5% of the Company's issued and outstanding common shares. The AAF will hold
an aggregate of 179,188,774 common shares representing approximately 32.5% of
the common shares. Completion of the investment by the remaining subscriber is
subject to customary terms and conditions as set out in the subscription
agreement with such investor.


CDC, which has net assets of approximately GBP 2.8bn, is wholly owned by the UK
Government's Department for International Development and uses its own balance
sheet to invest in the developing countries of Africa and South Asia. CDC's
mission is to support the building of businesses in Africa and South Asia,
creating jobs and making a lasting difference to people's lives in some of the
world's poorest places.


The Company has appointed one CDC nominee, Mr. Keith Alexander, to the Company's
Board of Directors. CDC also has the right to appoint a second nominee to the
Board of Directors. Mr. Alexander will serve on the Procurement Committee and
Chair a newly formed Environmental, Social, and Governance Committee of the
Board. Mr. Alexander has been involved with businesses operating in Africa for
over 25 years and most recently he was a director at Actis LLP where he was a
member of the management team of the Actis Africa Agribusiness Fund. Prior to
Actis, Mr. Alexander was employed by CDC where he focused on agribusiness
investments in emerging markets. Mr. Alexander will replace Mr. Philip Condon
who has stepped down as a director of the Company. The Company thanks Mr. Condon
for his service to Feronia during his tenure as a director.


The Company and CDC have also entered into a convertible loan agreement,
pursuant to which CDC will make available an unsecured non-revolving term loan
(the "Facility") up to a maximum amount of $3.6 million at an interest rate of
12% for a term of five years. The funds available under the Facility are
required to be used by the Company to support the implementation of an
Environmental and Social Action Plan ("ESAP") developed jointly with CDC. The
principal under the Facility will be convertible into common shares of the
Company on the maturity date and in certain other circumstances at a rate of
CAD$0.24 per common share (subject to customary adjustment provisions). Subject
to the approval of the TSX Venture Exchange (the "TSXV"), the interest payable
under the Facility will be convertible into common shares at a rate equal to the
greater of CAD$0.24 and the Discounted Market Price (as defined in TSXV policy)
at the time of conversion. Assuming that the maximum amount under the Facility
is advanced to the Company for the full term of five years, the outstanding
principal and interest would be convertible into up to approximately 26,500,000
common shares, subject to the Discounted Market Price and the exchange rate at
the time of conversion. For more information regarding the Facility, please see
the Company's news release dated November 8 entitled "Feronia Inc. Enters into
Loan Facility With CDC to Advance 'Environmental and Social Action Plan'".


Commenting, Ravi Sood, Chairman of Feronia said: "We are very pleased to close
this financing with CDC, the AAF and other participating investors, and wish to
thank our shareholders for their continued support.


"We have worked closely with CDC over the past few months to conclude this
investment, building on their experience and knowledge as a leading development
finance institution. To have the UK's DFI as a substantial investor in Feronia
is, we believe, confirmation of the potential of what we are doing and the
positive impact Feronia can have on the DRC. CDC's long-term investment will
allow us to build on what we have already achieved, generating and sustaining
new growth, jobs and investment in the DRC."


Commenting, Dolika Banda, CDC's Regional Director for Africa, said: "This is an
important investment in DRC for CDC. Feronia's plantations are at the heart of
their communities and it is a highly respected company within the country. One
of our key reasons for investing is the depth of experience in both the
workforce and senior management team, which is a testament to its 100-year
history in DRC. The company has already made significant progress in
rehabilitating plantations which were in a state of distress and we believe that
the business has substantial potential to be a major contributor to growth and
jobs in DRC.


"We will work closely with Feronia to ensure it has access to the long-term
capital and support it needs. We will also focus on building the company's value
by strengthening its environmental, social and governance standards, and
supporting it to move towards international standards in the palm oil industry."


About Feronia Inc.



--  Feronia Inc. is a large-scale commercial farmland and plantation
    operator in the Democratic Republic of the Congo ("DRC"). 
--  The Company uses modern agricultural practices to operate and develop
    its oil palm plantations and arable farming business division. 
--  Feronia believes in the immense agricultural potential of the DRC for
    high-quality foodstuffs and edible oils given its ideal climate,
    excellent soil and highly skilled and experienced workforce. 
--  Feronia's management team is comprised of senior agriculturalists with
    extensive experience in managing both plantations and large-scale
    mechanized farming operations in emerging markets. 
--  Feronia is committed to sustainable agriculture, environmental
    protection and providing support for local communities. 
--  For more information please see www.feronia.com.



About CDC

CDC is the UK government-owned development finance institution that uses its own
balance sheet to invest in the developing countries of South Asia and Africa. It
has net assets of GBP 2.8bn. CDC's mission is to support the building of
businesses in the poorest countries, creating jobs and making a lasting
difference to people's lives in some of the world's poorest places. Under its
recent business strategy, announced in September 2012, CDC provides debt and
direct investment to businesses as well as acting as a fund-of-funds investor.
CDC also now only makes new investment commitments in Africa and South Asia.
www.cdcgroup.com.


About Phatisa

Phatisa is a private equity fund manager, operating across sub-Saharan Africa,
operating from offices in Port Louis, Johannesburg, Lusaka, Nairobi, Accra and
London. Phatisa comprises a team with a significant track record of managing
private equity funds and agricultural businesses throughout the continent. The
Phatisa team is located in Africa and spends a considerable amount of time
developing relationships with strategic partners in all countries where funds
under management are active. This ensures that funds have reliable networks and
information in the countries in which they invest. Team members have a
reputation built up over the last decade, which can be seen in their track
records, on-the-ground network, and access to agricultural players and
facilities on the continent. Phatisa provides the experience necessary to
invest, manage and successfully exit what will be one of Africa's most
pioneering agricultural private equity funds. www.phatisa.com.


Cautionary Notes

Except for statements of historical fact contained herein, the information in
this press release constitutes "forward-looking information" within the meaning
of Canadian securities law. Such forward-looking information may be identified
by words such as "anticipates", "plans", "proposes", "estimates", "intends",
"expects", "believes", "may", "will" and include without limitation, statements
regarding the completion of subsequent tranches of the private placement and the
benefits to the Company of CDC's investment. There can be no assurance that such
statements will prove to be accurate; actual results and future events could
differ materially from such statements. Factors that could cause actual results
to differ materially include, among others, the inability to obtain the
additional subscription funds on terms acceptable to the Company or at all,
regulatory risks, risks inherent in foreign operations, commodity prices,
competition, and investments having no history of operations. Most of these
factors are outside the control of the Company. Investors are cautioned not to
put undue reliance on forward-looking information. Except as otherwise required
by applicable securities statutes or regulation, the Company expressly disclaims
any intent or obligation to update publicly forward-looking information, whether
as a result of new information, future events or otherwise.


Neither the TSX Venture Exchange nor its regulation services provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Feronia Inc.
Ravi Sood
Executive Chairman
+852 9829 8376
Ravi.Sood@feronia.com


Feronia Inc.
Bill Dry
CEO
44 (0) 7887 525 046
Bill.Dry@feronia.com


Feronia Inc.
Paul Dulieu
Investor Relations
44 (0) 7554 521421
Paul.Dulieu@feronia.com


CDC Group plc
Edgar Buckley
Head of Marketing and Public Engagement
44 (0)20 7963 4734 or 44(0) 7775 810 499
ebuckley@cdcgroup.com


CDC Group plc
Rhyddid Carter
Corporate Communications Manager
+44 (0)20 7963 4741 or +44(0) 7824 552 326
rcarter@cdcgroup.com


Phatisa
Izelle le Roux-Owen
Corporate Communications & Investor Relations
+ 27 11 463 1920
izelleleroux@phatisa.com

Cadillac Ventures (TSXV:CDC)
Historical Stock Chart
From Mar 2024 to Apr 2024

Cadillac Ventures (TSXV:CDC)
Historical Stock Chart
From Apr 2023 to Apr 2024